chr7-6498096-C-T
Position:
Variant summary
Our verdict is Uncertain significance. Variant got 2 ACMG points: 2P and 0B. PM2
The NM_001145118.2(GRID2IP):c.3532G>A(p.Gly1178Ser) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.00000709 in 1,551,370 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Genomes: 𝑓 0.000013 ( 0 hom., cov: 34)
Exomes 𝑓: 0.0000064 ( 0 hom. )
Consequence
GRID2IP
NM_001145118.2 missense
NM_001145118.2 missense
Scores
3
5
10
Clinical Significance
Conservation
PhyloP100: 7.41
Genes affected
GRID2IP (HGNC:18464): (Grid2 interacting protein) Glutamate receptor delta-2 (GRID2; MIM 602368) is predominantly expressed at parallel fiber-Purkinje cell postsynapses and plays crucial roles in synaptogenesis and synaptic plasticity. GRID2IP1 interacts with GRID2 and may control GRID2 signaling in Purkinje cells (Matsuda et al., 2006 [PubMed 16835239]).[supplied by OMIM, Mar 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Uncertain_significance. Variant got 2 ACMG points.
PM2
Very rare variant in population databases, with high coverage;
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
GRID2IP | NM_001145118.2 | c.3532G>A | p.Gly1178Ser | missense_variant | 21/22 | ENST00000457091.3 | |
GRID2IP | NM_001394781.1 | c.2983G>A | p.Gly995Ser | missense_variant | 20/21 | ||
GRID2IP | NM_001388403.1 | c.2959G>A | p.Gly987Ser | missense_variant | 20/21 | ||
GRID2IP | XM_047420365.1 | c.2962G>A | p.Gly988Ser | missense_variant | 20/21 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
GRID2IP | ENST00000457091.3 | c.3532G>A | p.Gly1178Ser | missense_variant | 21/22 | 5 | NM_001145118.2 | P1 | |
GRID2IP | ENST00000435185.5 | c.2980G>A | p.Gly994Ser | missense_variant | 20/21 | 5 | |||
GRID2IP | ENST00000452113.5 | c.2959G>A | p.Gly987Ser | missense_variant | 20/21 | 5 |
Frequencies
GnomAD3 genomes AF: 0.0000131 AC: 2AN: 152236Hom.: 0 Cov.: 34
GnomAD3 genomes
AF:
AC:
2
AN:
152236
Hom.:
Cov.:
34
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.00000642 AC: 1AN: 155678Hom.: 0 AF XY: 0.00 AC XY: 0AN XY: 82534
GnomAD3 exomes
AF:
AC:
1
AN:
155678
Hom.:
AF XY:
AC XY:
0
AN XY:
82534
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00000643 AC: 9AN: 1399134Hom.: 0 Cov.: 33 AF XY: 0.00000580 AC XY: 4AN XY: 690126
GnomAD4 exome
AF:
AC:
9
AN:
1399134
Hom.:
Cov.:
33
AF XY:
AC XY:
4
AN XY:
690126
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0000131 AC: 2AN: 152236Hom.: 0 Cov.: 34 AF XY: 0.00 AC XY: 0AN XY: 74360
GnomAD4 genome
AF:
AC:
2
AN:
152236
Hom.:
Cov.:
34
AF XY:
AC XY:
0
AN XY:
74360
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Dec 19, 2022 | The c.3532G>A (p.G1178S) alteration is located in exon 21 (coding exon 21) of the GRID2IP gene. This alteration results from a G to A substitution at nucleotide position 3532, causing the glycine (G) at amino acid position 1178 to be replaced by a serine (S). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
BayesDel_addAF
Benign
T
BayesDel_noAF
Benign
CADD
Pathogenic
DANN
Uncertain
DEOGEN2
Benign
T;.;T
Eigen
Pathogenic
Eigen_PC
Pathogenic
FATHMM_MKL
Uncertain
D
LIST_S2
Uncertain
D;D;D
M_CAP
Benign
T
MetaRNN
Uncertain
T;T;T
MetaSVM
Benign
T
MutationTaster
Benign
D;D;D
PrimateAI
Pathogenic
D
PROVEAN
Uncertain
D;D;D
REVEL
Benign
Sift
Benign
T;T;T
Sift4G
Benign
T;T;T
Polyphen
1.0
.;.;D
Vest4
MVP
MPC
0.53
ClinPred
D
GERP RS
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at